Status:

ACTIVE_NOT_RECRUITING

Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression

Lead Sponsor:

Turku University Hospital

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

40-55 years

Brief Summary

To evaluate the effect of teriflunomide treatment on microglial activation in late stage multiple sclerosis.

Detailed Description

In Multiple Sclerosis (MS), plaques in the white and grey matter of the brain represent the best known pathological changes of the disease, but a significant inflammation process has also been detecte...

Eligibility Criteria

Inclusion

  • Signing the consent form
  • Having used teriflunomide treatment for at least 6 months
  • 40-55 years of age at the time of signing the research consent form
  • MS diagnosis in accordance with either the Poser or McDonald criteria
  • EDSS 2-6.5
  • Clear lesion load in brain MRI (\> 9 T2 lesion)

Exclusion

  • Patients suffering from another brain disease of in addition to multiple sclerosis
  • Steroid treatment 4 weeks prior to the scan
  • Significant pathology in the MRI scan other than MS-related lesions
  • Patients suffering from claustrophobia or panic disorder, or patients who have exhibited hypersensitivity of PET markers (practical obstacle to the scan)
  • Exposure to experimental radioactivity in the last 12 months such that the dosimetry threshold would be exceeded due to participation in the study
  • Severe hepatic impairment
  • Pregnant women, or women of childbearing potential who are not using reliable contraception during treatment with teriflunomide and thereafter as long as its plasma levels are above 0.02 mg/l.

Key Trial Info

Start Date :

December 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2027

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT03368677

Start Date

December 1 2017

End Date

December 1 2027

Last Update

April 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Turku PET Centre

Turku, Southwest Finland, Finland, 20520